Kobayashi Pharmaceutical Co's total assets for Q2 2025 were ¥260.71B, an increase of 3.56% from the previous quarter. JP:4967 total liabilities were ¥52.47B for the fiscal quarter, a 17.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.